Dr. Helmut M. Schuehsler serves as Chairman and Managing Partner within TVM Capital Group, TVM Capital Life Science, Munich/Montreal and as Chief Executive Officer of TVM Capital Health care Partners Ltd., Dubai.
Since joining TVM Capital in 1990, Dr. Schuehsler has been the deal maker on more than 30 direct investments in life science companies. In total he has overseen more than 100 investments as a managing partner or CEO in the health market with over 40 going public in the United States and Europe. He has built the TVM Capital Life Science practice as an internal start up within the firm to its market position today.
In addition to his board seat at Biovertis, he is member of the board at Concert Pharmaceuticals (Lexington, MA, USA) and F-Star (UK, Austria). He also serves as chairman of Manzil Health Care Services (UAE/ Egypt) and previously held the position of chairman at ProVita International Medical Center (UAE) Cambridge Medical & Rehabilitation Center (UAE) and Bourn Hall International (UAE/India).
For more than 10 years, he served on the board of Max-Planck Innovation GmbH. In 2007 and 2008, Dr. Schuehsler held the position of chairman of the European Private Equity and Venture Capital Association (EVCA now called “Invest Europe”). Dr. Schuehsler was a member of the Selection Committee for the Technology Pioneers program, the Steering Committee of the Entrepreneurship and Successful Growth Research Program of the World Economic Forum (2009-2012), and the advisory board of Evolvence India Life Science Fund, Hyderabad, India.